Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice

Natalie E de Picciotto, Lindsey B Gano, Lawrence C Johnson, Christopher R Martens, Amy L Sindler, Kathryn F Mills, Shin-Ichiro Imai, Douglas R Seals, Natalie E de Picciotto, Lindsey B Gano, Lawrence C Johnson, Christopher R Martens, Amy L Sindler, Kathryn F Mills, Shin-Ichiro Imai, Douglas R Seals

Abstract

We tested the hypothesis that supplementation of nicotinamide mononucleotide (NMN), a key NAD(+) intermediate, increases arterial SIRT1 activity and reverses age-associated arterial dysfunction and oxidative stress. Old control mice (OC) had impaired carotid artery endothelium-dependent dilation (EDD) (60 ± 5% vs. 84 ± 2%), a measure of endothelial function, and nitric oxide (NO)-mediated EDD (37 ± 4% vs. 66 ± 6%), compared with young mice (YC). This age-associated impairment in EDD was restored in OC by the superoxide (O2-) scavenger TEMPOL (82 ± 7%). OC also had increased aortic pulse wave velocity (aPWV, 464 ± 31 cm s(-1) vs. 337 ± 3 cm s(-1) ) and elastic modulus (EM, 6407 ± 876 kPa vs. 3119 ± 471 kPa), measures of large elastic artery stiffness, compared with YC. OC had greater aortic O2- production (2.0 ± 0.1 vs. 1.0 ± 0.1 AU), nitrotyrosine abundance (a marker of oxidative stress), and collagen-I, and reduced elastin and vascular SIRT1 activity, measured by the acetylation status of the p65 subunit of NFκB, compared with YC. Supplementation with NMN in old mice restored EDD (86 ± 2%) and NO-mediated EDD (61 ± 5%), reduced aPWV (359 ± 14 cm s(-1) ) and EM (3694 ± 315 kPa), normalized O2- production (0.9 ± 0.1 AU), decreased nitrotyrosine, reversed collagen-I, increased elastin, and restored vascular SIRT1 activity. Acute NMN incubation in isolated aortas increased NAD(+) threefold and manganese superoxide dismutase (MnSOD) by 50%. NMN supplementation may represent a novel therapy to restore SIRT1 activity and reverse age-related arterial dysfunction by decreasing oxidative stress.

Keywords: NAD+; SIRT1; arterial stiffness; endothelial dysfunction; oxidative stress.

© 2016 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.

Figures

Figure 1
Figure 1
Endothelium‐dependent, nitric oxide (NO)‐dependent, and endothelium‐independent dilation. (A) Dose–responses to the endothelium‐dependent dilator acetylcholine (ACh) in young and old control (YC and OC) and young and old NMN‐supplemented (YNMN and ONMN) mice (n = 13–22 per group). (B) NO‐dependent dilation (Max DilationACh − Max DilationACh + l‐NAME) (n = 5–12 per group). (C) Dose–responses to the endothelium‐independent dilator sodium nitroprusside (SNP) (n = 7–22 per group). Values are mean ± SEM. *< 0.05 vs. all.
Figure 2
Figure 2
Vascular oxidative stress. (A) Maximal dose–response to the endothelium‐dependent dilator acetylcholine (ACh) in young and old control (YC and OC) and young and old NMN‐supplemented (YNMN and ONMN) mice in the presence or absence of TEMPOL (n = 5–9 per group) *P < 0.05 vs. TEMPOL. (B) Superoxide production, assessed by electron paramagnetic resonance (EPR). Values are normalized to YC mean value. Representative EPR signal below (n = 4–9 per group). (C) Nitrotyrosine (NT) abundance in aorta. Data are expressed relative to α‐smooth muscle actin and normalized to YC mean value. Representative Western blot images below (n = 4–6 per group). Values are mean ± SEM. *< 0.05 vs. all; # < 0.05 vs. YC.
Figure 3
Figure 3
Large elastic artery stiffness. (A) Aortic pulse wave velocity (aPWV) in young and old control (YC and OC) and young and old NMN‐supplemented (YNMN and ONMN) mice (n = 5–9 per group). (B) Elastic modulus (n = 5–6 per group). (C) Total collagen 1 (Col 1) expression in aorta (n = 4–9 per group). (D) Total elastin expression in aorta. Values normalized to YC mean value. Representative images below (n = 4–11 per group). Values are mean ± SEM. Bars = 100 μm. *< 0.05 vs. all; # < 0.05 vs. YC.
Figure 4
Figure 4
SIRT1 expression and activity. (A) SIRT1 expression in aorta of young and old control (YC and OC) and young and old NMN‐supplemented (YNMN and ONMN) mice (n = 5–7 per group). (B) Ratio of acetylated to total NFκB in aorta (n = 5–11 per group). Data are expressed relative to α‐smooth muscle actin and normalized to YC mean value. Representative Western blot images below. Values are mean ± SEM. #< 0.05 vs. YC; †< 0.05 vs. OC.
Figure 5
Figure 5
NAD+ and MnSOD. (A) NAD+ production in aortas from young mice incubated in vitro with vehicle or NMN for 48 h (n = 3–5 per group). (B) Manganese superoxide dismutase (MnSOD) expression in aortas from old mice incubated in vitro with vehicle or NMN for 48 h (n = 4–5 per group). Values normalized to vehicle mean value. Representative images below. Values are mean ± SEM. Bars = 100 μm. *P < 0.05.

References

    1. Akhtar R, Sherratt MJ, Cruickshank JK, Derby B (2011) Characterizing the elastic properties of tissues. Mater. Today 14, 96–105.
    1. Bachschmid MM, Schildknecht S, Matsui R, Zee R, Haeussler D, Cohen RA, Pimental D, Loo B (2013) Vascular aging: chronic oxidative stress and impairment of redox signaling‐consequences for vascular homeostasis and disease. Ann. Med. 45, 17–36.
    1. Boily G, Seifert EL, Bevilacqua L, He XH, Sabourin G, Estey C, Moffat C, Crawford S, Saliba S, Jardine K, Xuan J, Evans M, Harper ME, McBurney MW (2008) SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One 3, e1759.
    1. Canto C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y, Fernandez‐Marcos PJ, Yamamoto H, Andreux PA, Cettour‐Rose P, Gademann K, Rinsch C, Schoonjans K, Sauve AA, Auwerx J (2012) The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high‐fat diet‐induced obesity. Cell Metab. 15, 838–847.
    1. Csiszar A, Ungvari Z, Edwards JG, Kaminski P, Wolin MS, Koller A, Kaley G (2002) Aging‐induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ. Res. 90, 1159–1166.
    1. Csiszar A, Labinskyy N, Jimenez R, Pinto JT, Ballabh P, Losonczy G, Pearson KJ, de Cabo R, Ungvari Z (2009) Anti‐oxidative and anti‐inflammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1. Mech. Ageing Dev. 130, 518–527.
    1. Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115, 1285–1295.
    1. Diez J (2007) Arterial stiffness and extracellular matrix. Adv. Cardiol. 44, 76–95.
    1. Donato AJ, Magerko KA, Lawson BR, Durrant JR, Lesniewski LA, Seals DR (2011) SIRT‐1 and vascular endothelial dysfunction with ageing in mice and humans. J. Physiol. 589, 4545–4554.
    1. Donato AJ, Walker AE, Magerko KA, Bramwell RC, Black AD, Henson GD, Lawson BR, Lesniewski LA, Seals DR (2013) Life‐long caloric restriction reduces oxidative stress and preserves nitric oxide bioavailability and function in arteries of old mice. Aging Cell 12, 772–783.
    1. Fleenor BS, Marshall KD, Durrant JR, Lesniewski LA, Seals DR (2010) Arterial stiffening with ageing is associated with transforming growth factor‐beta1‐related changes in adventitial collagen: reversal by aerobic exercise. J. Physiol. 588, 3971–3982.
    1. Fleenor BS, Seals DR, Zigler ML, Sindler AL (2012a) Superoxide‐lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice. Aging Cell 11, 269–276.
    1. Fleenor BS, Sindler AL, Eng JS, Nair DP, Dodson RB, Seals DR (2012b) Sodium nitrite de‐stiffening of large elastic arteries with aging: role of normalization of advanced glycation end‐products. Exp. Gerontol. 47, 588–594.
    1. Fleenor BS, Sindler AL, Marvi NK, Howell KL, Zigler ML, Yoshizawa M, Seals DR (2013) Curcumin ameliorates arterial dysfunction and oxidative stress with aging. Exp. Gerontol. 48, 269–276.
    1. Fornieri C, Taparelli F, Quaglino D Jr, Contri MB, Davidson JM, Algeri S, Ronchetti IP (1999) The effect of caloric restriction on the aortic tissue of aging rats. Connect. Tissue Res. 40, 131–143.
    1. Gano LB, Donato AJ, Pasha HM, Hearon CM Jr, Sindler AL, Seals DR (2014) The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice. Am. J. Physiol. Heart Circ. Physiol. 307, H1754–H1763.
    1. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Menzoian JO, Vita JA (2002) Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 105, 1567–1572.
    1. Gomes AP, Price NL, Ling AJ, Moslehi JJ, Montgomery MK, Rajman L, White JP, Teodoro JS, Wrann CD, Hubbard BP, Mercken EM, Palmeira CM, de Cabo R, Rolo AP, Turner N, Bell EL, Sinclair DA (2013) Declining NAD(+) induces a pseudohypoxic state disrupting nuclear‐mitochondrial communication during aging. Cell 155, 1624–1638.
    1. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd‐Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ, American Heart Association Advocacy Coordinating Committee , Stroke Council , Council on Cardiovascular Radiology and Intervention , Council on Clinical Cardiology , Council on Epidemiology and Prevention , Council on Arteriosclerosis , Thrombosis and Vascular Biology , Council on Cardiopulmonary , Critical Care , Perioperative and Resuscitation , Council on Cardiovascular Nursing , Council on the Kidney in Cardiovascular Disease , Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research (2011) Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 123, 933–944.
    1. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T (2001) Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104, 2673–2678.
    1. Hughes‐Large JM, Pang DK, Robson DL, Chan P, Toma J, Borradaile NM (2014) Niacin receptor activation improves human microvascular endothelial cell angiogenic function during lipotoxicity. Atherosclerosis 237, 696–704.
    1. Humphrey JD (2002) Cardiovascular Solid Mechanics. Cells, Tissues, and Organs. New York: Springer.
    1. Imai S (2010) A possibility of nutriceuticals as an anti‐aging intervention: activation of sirtuins by promoting mammalian NAD biosynthesis. Pharmacol. Res. 62, 42–47.
    1. Lakatta EG, Levy D (2003) Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation 107, 139–146.
    1. LaRocca TJ, Gioscia‐Ryan RA, Hearon CM Jr, Seals DR (2013) The autophagy enhancer spermidine reverses arterial aging. Mech. Ageing Dev. 134, 314–320.
    1. Marcu R, Kotha S, Zhi Z, Qin W, Neeley CK, Wang RK, Zheng Y, Hawkins BJ (2015) The mitochondrial permeability transition pore regulates endothelial bioenergetics and angiogenesis. Circ. Res. 116, 1336–1345.
    1. Merksamer PI, Liu Y, He W, Hirschey MD, Chen D, Verdin E (2013) The sirtuins, oxidative stress and aging: an emerging link. Aging (Albany NY). 5, 144–150.
    1. Mitchell GF (2014) Arterial stiffness and hypertension. Hypertension 64, 13–18.
    1. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ (2010) Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 121, 505–511.
    1. Mortality GBD, Causes of Death C (2014) Global, regional, and national age‐sex specific all‐cause and cause‐specific mortality for 240 causes of death, 1990‐2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385, 117–171.
    1. Nakamura M, Bhatnagar A, Sadoshima J (2012) Overview of pyridine nucleotides review series. Circ. Res. 111, 604–610.
    1. Peserico A, Simone C (2011) Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J. Biomed. Biotechnol. 2011, 371832.
    1. Petsko GA (2008) A seat at the table. Genome Biol. 9, 113.
    1. Pfluger PT, Herranz D, Velasco‐Miguel S, Serrano M, Tschop MH (2008) Sirt1 protects against high‐fat diet‐induced metabolic damage. Proc. Natl Acad. Sci. USA 105, 9793–9798.
    1. Ramsey KM, Mills KF, Satoh A, Imai S (2008) Age‐associated loss of Sirt1‐mediated enhancement of glucose‐stimulated insulin secretion in beta cell‐specific Sirt1‐overexpressing (BESTO) mice. Aging Cell 7, 78–88.
    1. Reddy AK, Li YH, Pham TT, Ochoa LN, Trevino MT, Hartley CJ, Michael LH, Entman ML, Taffet GE (2003) Measurement of aortic input impedance in mice: effects of age on aortic stiffness. Am. J. Physiol. Heart Circ. Physiol. 285, H1464–H1470.
    1. Rippe C, Lesniewski L, Connell M, LaRocca T, Donato A, Seals D (2010) Short‐term calorie restriction reverses vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stress. Aging Cell 9, 304–312.
    1. Satoh A, Stein L, Imai S (2011) The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity. Handb. Exp. Pharmacol. 206, 125–162.
    1. Seals DR, Jablonski KL, Donato AJ (2011) Aging and vascular endothelial function in humans. Clin. Sci. 120, 357–375.
    1. Seals DR, Kaplon RE, Gioscia‐Ryan RA, LaRocca TJ (2014) You're only as old as your arteries: translational strategies for preserving vascular endothelial function with aging. Physiology (Bethesda). 29, 250–264.
    1. Sindler AL, Fleenor BS, Calvert JW, Marshall KD, Zigler ML, Lefer DJ, Seals DR (2011) Nitrite supplementation reverses vascular endothelial dysfunction and large elastic artery stiffness with aging. Aging Cell 10, 429–437.
    1. Someya S, Yu W, Hallows WC, Xu J, Vann JM, Leeuwenburgh C, Tanokura M, Denu JM, Prolla TA (2010) Sirt3 mediates reduction of oxidative damage and prevention of age‐related hearing loss under caloric restriction. Cell 143, 802–812.
    1. Stein LR, Imai S (2014) Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging. EMBO J. 33, 1321–1340.
    1. Sutton‐Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, Havlik R, Lakatta EG, Spurgeon H, Kritchevsky S, Pahor M, Bauer D, Newman A, Health ABCS (2005) Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well‐functioning older adults. Circulation 111, 3384–3390.
    1. Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all‐cause mortality with arterial stiffness: a systematic review and meta‐analysis. J. Am. Coll. Cardiol. 55, 1318–1327.
    1. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA (2003) The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol. 42, 1149–1160.
    1. Xiong S, Salazar G, Patrushev N, Alexander RW (2011) FoxO1 mediates an autofeedback loop regulating SIRT1 expression. J. Biol. Chem. 286, 5289–5299.
    1. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM (2007) Brachial flow‐mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 115, 2390–2397.
    1. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF‐kappaB‐dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369–2380.
    1. Yoshino J, Mills KF, Yoon MJ, Imai S (2011) Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet‐ and age‐induced diabetes in mice. Cell Metab. 14, 528–536.
    1. Zieman SJ, Melenovsky V, Kass DA (2005) Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler. Thromb. Vasc. Biol. 25, 932–943.

Source: PubMed

3
Suscribir